PedAM
Pediatric Disease Annotations & Medicines
| Disease | osteoporosis |
| Phenotype | C0035435|rheumatic disease |
| Sentences | 4 |
| PubMedID- 24261336 | Exclusion criteria were patients in need of surgical treatment, cauda equina syndrome, and symptomatic spinal deformities, osteoporosis with fractures, inflammatory rheumatic diseases, other serious somatic or mental diseases, pregnancy, legal labour dispute, and insufficient norwegian language to fill in the questionnaires. |
| PubMedID- 25896785 | Additional exclusion criteria were: cauda equina syndrome; symptomatic spinal deformity; osteoporosis with fracture; inflammatory rheumatic disease; pregnancy; legal labour dispute; insufficient norwegian language skills; cardiac, pulmonary, or metabolic disease with functional restrictions; and dsm-v-diagnosed mental disorders. |
| PubMedID- 20406615 | Objectives: in the 18 month "alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial (stop-trial) patients with rheumatic diseases who started glucocorticoids were randomised to anti-osteoporosis therapy with either daily alendronate (10 mg) or alfacalcidol (1 microg). |
| PubMedID- 24324644 | It is clinically important to determine the efficacy of bps on the prevention and treatment of osteoporosis in patients with rheumatic diseases. |
Page: 1